Over the 29th-31st May 2020 The American Society for Clinical Oncology (ASCO) held their annual meeting in a virtual format. ASCO aims to bring together perspectives from different disciplines to discover new research avenues and revolutionize the future of clinical oncology.
In this video, The Nanomed Zone Editor, Lucy Chard discusses one of her highlights as the use of nanosized dendrimers for controlled release of drugs at the tumor site in hepatocellular carcinoma treatment. This research is one of many abstracts presented a the virtual conference showcasing how nanomedicine is being used in clinical oncology. Further highlights on the nano-oncological research has been summarized in this news round up from the event >>>
For more news and content from ASCO20, visit Oncology Central here.